Author:
Wang Li,Jiang Lei,Pan Dongyan,Wang Qinghua,Yin Zeyu,Kang Zijian,Tian Haoran,Geng Xuqiang,Shao Jinsong,Pan Wenjie,Yin Jian,Fang Li,Wang Yue,Zhang Weide,Li Zhixiu,Zheng Jun,Hu Wenxin,Pan Yunbao,Yu Dong,Guo Shicheng,Lu Wei,Li Qiang,Zhou Yunyun,Xu Huji
Reference35 articles.
1. Clinical characteristics of coronavirus disease 2019 in China;Guan;N Engl J Med,2020
2. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China;Wang;JAMA,2020
3. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study;Chen;Lancet,2020
4. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2;Zhou;Cell Discov,2020
5. Xing J, Shankar R, Drelich A, Paithankar S, Chekalin E, Dexheimer T, et al. Reversal of infected host gene expression identifies repurposed drug candidates for COVID-19. bioRxiv:2020.04.07.030734v1[Preprint]. 2020[cited 15 December 2020]. Available from: https://www.biorxiv.org/content/10.1101/2020.04.07.030734v1
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献